Xiaohui Wang1, Tuanzhu Ha1, Jianghuan Zou2, Danyang Ren1, Li Liu3, Xia Zhang1, John Kalbfleisch4, Xiang Gao2, David Williams1, Chuanfu Li5. 1. Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Campus Box 70575, Johnson City, TN 37614-0575, USA. 2. Animal Model Research Center, Nanjing University, Nanjing 210093, China. 3. Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. 4. Department of Biometry and Medical Computing, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. 5. Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Campus Box 70575, Johnson City, TN 37614-0575, USA li@etsu.edu.
Abstract
AIMS: The present study examined the role of microRNA-125b (miR-125b) in myocardial ischaemia/reperfusion (I/R) injury. We constructed lentivirus-expressing miR-125b (LmiR-125b) and developed transgenic mice with overexpression of miR-125b. METHODS AND RESULTS: LmiR-125b was transfected into mouse hearts through the right common carotid artery. Lentivirus vector (LmiR-Con) served as vector control. Untreated mice served as I/R control. Sham operation served as sham control. Seven days after transfection, the hearts were subjected to ischaemia (45 min) followed by reperfusion (4 h). Myocardial infarct size was analysed by 2,3,5-triphenyltetrazolium chloride staining. In separate experiments, hearts were subjected to ischaemia (45 min) followed by reperfusion for up to 7 days. Cardiac function was measured by echocardiography before, as well as 3 and 7 days after myocardial I/R. Increased expression of miR-125b significantly decreased I/R-induced myocardial infarct size by 60% and prevented I/R-induced decreases in ejection fraction (EF%) and fractional shortening (%FS). Transgenic mice with overexpression of miR-125b also showed the protection against myocardial I/R injury. Increased expression of miR-125b attenuated I/R-induced myocardial apoptosis and caspase-3/7 and -8 activities. Western blot showed that increased expression of miR-125b suppresses p53 and Bak1 expression in the myocardium. In addition, transfection of LmiR-125b decreased the levels of TNF receptor-associated factor 6 (TRAF6) and prevented I/R-induced NF-κB activation. CONCLUSION: miR-125 protects the myocardium from I/R injury by preventing p53-mediated apoptotic signalling and suppressing TRAF6-mediated NF-κB activation. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The present study examined the role of microRNA-125b (miR-125b) in myocardial ischaemia/reperfusion (I/R) injury. We constructed lentivirus-expressing miR-125b (LmiR-125b) and developed transgenic mice with overexpression of miR-125b. METHODS AND RESULTS: LmiR-125b was transfected into mouse hearts through the right common carotid artery. Lentivirus vector (LmiR-Con) served as vector control. Untreated mice served as I/R control. Sham operation served as sham control. Seven days after transfection, the hearts were subjected to ischaemia (45 min) followed by reperfusion (4 h). Myocardial infarct size was analysed by 2,3,5-triphenyltetrazolium chloride staining. In separate experiments, hearts were subjected to ischaemia (45 min) followed by reperfusion for up to 7 days. Cardiac function was measured by echocardiography before, as well as 3 and 7 days after myocardial I/R. Increased expression of miR-125b significantly decreased I/R-induced myocardial infarct size by 60% and prevented I/R-induced decreases in ejection fraction (EF%) and fractional shortening (%FS). Transgenic mice with overexpression of miR-125b also showed the protection against myocardial I/R injury. Increased expression of miR-125b attenuated I/R-induced myocardial apoptosis and caspase-3/7 and -8 activities. Western blot showed that increased expression of miR-125b suppresses p53 and Bak1 expression in the myocardium. In addition, transfection of LmiR-125b decreased the levels of TNF receptor-associated factor 6 (TRAF6) and prevented I/R-induced NF-κB activation. CONCLUSION:miR-125 protects the myocardium from I/R injury by preventing p53-mediated apoptotic signalling and suppressing TRAF6-mediated NF-κB activation. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore Journal: Proc Natl Acad Sci U S A Date: 2006-08-02 Impact factor: 11.205
Authors: Vanessa P M van Empel; Anne T A Bertrand; Leo Hofstra; Harry J Crijns; Pieter A Doevendans; Leon J De Windt Journal: Cardiovasc Res Date: 2005-07-01 Impact factor: 10.787
Authors: Esmerina Tili; Jean-Jacques Michaille; Amelia Cimino; Stefan Costinean; Calin Dan Dumitru; Brett Adair; Muller Fabbri; Hannes Alder; Chang Gong Liu; George Adrian Calin; Carlo Maria Croce Journal: J Immunol Date: 2007-10-15 Impact factor: 5.422
Authors: Fang Hua; Tuanzhu Ha; Jing Ma; Yan Li; Jim Kelley; Xiang Gao; I William Browder; Race L Kao; David L Williams; Chuanfu Li Journal: J Immunol Date: 2007-06-01 Impact factor: 5.422
Authors: Ming Gao; Xiaohui Wang; Xia Zhang; Tuanzhu Ha; He Ma; Li Liu; John H Kalbfleisch; Xiang Gao; Race L Kao; David L Williams; Chuanfu Li Journal: J Immunol Date: 2015-06-05 Impact factor: 5.422
Authors: Maryam Syed; Jana P Ball; Keisa W Mathis; Michael E Hall; Michael J Ryan; Marc E Rothenberg; Licy L Yanes Cardozo; Damian G Romero Journal: Am J Physiol Endocrinol Metab Date: 2018-08-28 Impact factor: 4.310
Authors: He Ma; Xiaohui Wang; Tuanzhu Ha; Ming Gao; Li Liu; Ruitao Wang; Kaijiang Yu; John H Kalbfleisch; Race L Kao; David L Williams; Chuanfu Li Journal: J Infect Dis Date: 2016-09-28 Impact factor: 5.226
Authors: Edwina Wing-Lun; Sally A Eaton; Suzy S J Hur; Alastair Aiken; Paul E Young; Michael E Buckland; Cheryl C Y Li; Jennifer E Cropley; Catherine M Suter Journal: Epigenetics Date: 2016-05-23 Impact factor: 4.528